You are here

SARC022

Active
A phase 2 study of OSI-906 in pediatic and adult wild type gastrointestinal stromal tumors
Type of Sarcoma: 
gastrointestinal stromal tumors
Drug: 
OSI-906
Accrual Status: 
Open, Not Accruing
Overall Study Principal Investigator: 

Margaret von Mehren, MD
Fox Chase Cancer Center

For more information about this trial and open sites: